876 results found

The Agency first announced on its official website on 4 January 2024, that the Guidelines on Scientific Meetings and Educational Activities to be Conducted within the Scope of the Regulation...

Beşerî Tıbbi Ürünler Fiyatlandırılmasına Dair Kararda değişiklik yapılmış olup bu karar, 19 Şubat 2021 tarihli ve 31400 sayılı Resmî Gazete'de yayımlanarak aynı gün yürürlüğe girdi.

Regulation Amending the Regulation on the Safety of Medicines was published in the Official Gazette dated 21 July 2022 and numbered 31899 and entered into force on the same date.

The Turkish Medicines and Medical Devices Agency ("TİTCK") recently announced the results of its cosmetics sector market surveillance and inspection conducted between January and March 2020.

he decision of the Council of Ministers adding to the Decision on the Pricing of Human Medical Products a currency provision effective as of 19 February 2021, was published on even date in Official Gazette numbered 31400.

On 6 May 2021, the Turkish Medicines and Medical Devices Agency published an announcement (Turkish language) about the transfer of value notifications ...

On 18 May 2018, the amendment (Turkish language) made on the "Law on the payment by the Ministry of Finance of accumulated unpaid debts to medical device companies arising from the purchase of drugs and medical devices by state university hospitals", was published in the Official Gazette numbered 30425.

The Regulation on the Sale, Advertisement, and Promotion of Medical Devices ("Medical Device Promotion Regulation"), the legislation containing detailed provisions on the sale...

A new provision has been incorporated into Article 8 titled "Foreign Currency Denominated and Foreign Currency Indexed Contracts" of the Communiqué (No: 2008-32/34) on the Decree No. 32 on the Protection.

The Euro exchange rate used for approval of medicine prices in Turkey is determined as per the Decision on Pricing of Human Medicinal Products ("Decision").

Turkish Pharmaceuticals and Medical Devices Agency has recently announced that the sanctions for sales centers provided under the Article 28/5 regarding the breach of Article 21 of the ...

On 19 January 2026, the Turkish Medicines and Medical Devices Agency announced a new initiative focusing on real-world data and pharmacoeconomic...

The Turkish Medicines and Medical Devices Agency recently announced the extension of the validity period of GMP certificates due to the pandemic.

On 18 May 2021, the Turkish Medicine and Medical Devices Authority (TİTCK) updated the Guidelines on Non-Clinical Assessment for Vaccines ("Guidelines").

Turkish Medicines and Medical Devices Authority published 280 announcements in 2020. 56 of these announcements are in relation to battle against COVID-19.

The supply of pharmaceutical products to Turkey via the named patient programme (the "NPP") is one of the exceptional importation regimes for pharmaceutical products.

For a long period of time, the pharmaceuticals industry needed a special model of reimbursement where the reimbursement conditions could be set, together through negotiation with the SSI...

Counterfeit and illicitly traded health products remained a persistent concern in Türkiye throughout 2025, as reflected both in enforcement statistics and in external reporting on supply chain integrity.